CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy

Dae-Won Lee, Seock-Ah Im, Yu Jung Kim, Yaewon Yang, Jiyoung Rhee, Im Il Na, Kyung-Hun Lee, Tae-Yong Kim, Sae-Won Han, In Sil Choi, Do-Youn Oh, Jee Hyun Kim, Tae-You Kim, Yung-Jue Bang

Cancer Research and Treatment. 2017;49(3):807-815. Published online 2017 January 18 DOI: https://doi.org/10.4143/crt.2016.326

CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy

Dae-Won Lee, Seock-Ah Im, Yu Jung Kim, Yaewon Yang, Jiyoung Rhee, Im Il Na, Kyung-Hun Lee, Tae-Yong Kim, Sae-Won Han, In Sil Choi, Do-Youn Oh, Jee Hyun Kim, Tae-You Kim, Yung-Jue Bang

Cancer Research and Treatment. 2017;49(3):807-815

Link1

Link2 Link3

Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin chemotherapy: retrospective analysis of 142 patients

H. Engin

Annals of Oncology. 2018;29:v29

Link1 Link2 Link3

Gemcitabine Plus Cisplatin Versus Gemcitabine Chemotherapy for Advanced Biliary Tract Cancer

Jinmyung Park, Jikon Ryu

Annals of Oncology. 2013;24:iv70

Link1 Link2 Link3

Gemcitabine plus Cisplatin versus Capecitabine plus Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer: A Retrospective Cohort Study

Sang Myung Woo, Woo Jin Lee, Ji Hun Kim, Dong Hwan Kim, Sung-Sik Han, Sang-Jae Park, Tae Hyun Kim, Ju Hee Lee, Young Hwan Koh, Eun Kyung Hong

Chemotherapy. 2013;59(3):232-238

Link1 Link2

Efficacy of fluoropyrimidine-based chemotherapy in patients with advanced biliary tract cancer after failure of gemcitabine plus cisplatin: retrospective analysis of 321 patients

Bum Jun Kim, Changhoon Yoo, Kyu-pyo Kim, Jaewon Hyung, Seong Joon Park, Baek-Yeol Ryoo, Heung-Moon Chang

British Journal of Cancer. 2017;116(5):561-567

Link1

Link2 Link3

Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy

Yuko Suzuki, Motoyasu Kan, Gen Kimura, Kumiko Umemoto, Kazuo Watanabe, Mitsuhito Sasaki, Hideaki Takahashi, Yusuke Hashimoto, Hiroshi Imaoka, Izumi Ohno, Shuichi Mitsunaga, Masafumi Ikeda

Journal of Gastroenterology. 2018;54(3):281-290

Link1 Link2

Link3

Comparison between Fluoropyrimidine-Cisplatin and Gemcitabine-Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer: A Meta-Analysis

Ting Zheng, Jianjiang Jin, Li Zhou, Yuefeng Zhang

Oncology Research and Treatment. 2020;43(9):460-469

Link1 Link2

Advanced seminoma?Treatment results and prognostic factors for survival after first-line, cisplatin-based chemotherapy and for patients with recurrent disease

Dany Gholam, Karim Fizazi, Marie-Jose Terrier-Lacombe, Pascale Jan, Stephane Culine, Christine Theodore

Cancer. 2003;98(4):745-752

Link1 Link2

CA19-9-related tumor kinetics after first-line chemotherapy of patients with advanced pancreatic cancer: a monoinstitutional experience

Giuseppe Colloca, Antonella Venturino, Domenico Guarneri

Medical Oncology. 2016;33(9):

Link1

Link2 Link3

CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy

Nazik HAMMAD, Lance K HEILBRUN, Philip A PHILIP, Anthony F SHIELDS, Mark M ZALUPSKI, Raghu VENKATRAMANAMOORTHY, Bassel F EL-RAYES

Asia-Pacific Journal of Clinical Oncology. 2010;6(2):98-105

Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.